Non Invasive Prenatal Testing (NIPT) Market Worth $7.3 billion by 2024 - Exclusive Report by MarketsandMarkets™

CHICAGO, Sept. 9, 2019 /PRNewswire/ -- According to the new market research report "Non Invasive Prenatal Testing (NIPT) Market by Product (Consumables, Reagent, Ultrasound, NGS, PCR, Microarray), Services, Method (cfDNA, Biochemical Markers), Application (Aneuploidy, Microdeletion) & End-User (Hospital, Labs)-Global Forecasts to 2024", published by MarketsandMarkets™, the Non Invasive Prenatal Testing (NIPT) Market is estimated to reach USD 7.3 billion by 2024 from USD 3.9 billion in 2019, at a CAGR of 13.5% during the forecast period. 

Download PDF Brochure:

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=145607690

The major factors driving the growth of this Non Invasive Prenatal Testing (NIPT) Market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, the launch of new and advanced NIPT products, and increasing maternal age (growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT Market during the forecast period. On the other hand, a dearth of skilled professionals is expected to restrain the growth of this market in the coming years. 

"The services segment is expected to grow at the highest CAGR during the forecast period."

On the basis of product and service, the NIPT Market is segmented into products and services. The services segment is expected to grow at the highest CAGR during the forecast period. Factors such as the rising incidence of genetic disorders, increasing focus on prenatal screening, and government initiatives to provide prenatal testing services are contributing to the growth of this market.

Browse in-depth TOC on "Non Invasive Prenatal Testing (NIPT) Market"

112 – Tables
31 – Figures  
144 – Pages

"The trisomy segment accounted for the largest share of the market in 2018."

On the basis of application, the NIPT Market is segmented into trisomy, microdeletion syndrome, and other applications. The trisomy segment accounted for the largest share of the non-invasive prenatal testing market in 2018. This segment is also expected to register the highest CAGR during the forecast period. The large share and high growth of this segment can primarily be attributed to the increasing maternal age and the rising incidence of chromosomal abnormalities.

Get Free 10% Customization on this Report:

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=145607690

"North America dominated the NIPT Market in 2018."

In 2018, North America dominated the Non Invasive Prenatal Testing (NIPT) Market, followed by Europe. The large share of this market can primarily be attributed to the strong economies in the US and Canada, which have allowed for significant investments in technology in this region. Growth in the North American market is supported by the presence of a better reimbursement structure and a favorable funding scenario for research activities, rising awareness about NIPT, and the increasing demand for the early detection of birth defects in this region.

The prominent players in the Non Invasive Prenatal Testing (NIPT) Market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), GE Healthcare (US), BGI (China), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PerkinElmer Inc. (US), Laboratory Corporation of America Holdings (US), Natera, Inc. (US), and Yourgene Health (UK)

Browse Adjacent Markets: Biotechnology Market Research Reports & Consulting

Browse Related Reports:

Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024

Ultrasound Market by Technology (Diagnostic, FUS, SWL), Display (Color, B/W), Portability (Trolley, Compact, Portable, POC), Application (Radiology, OB/GYN, Urology, Cardiology, Orthopedic), End user (Hospitals, ACC, Diagnostic Centers) - Forecast to 2023

About MarketsandMarkets™ 

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/non-invasive-prenatal-testing-market.asp
Visit Our Website: https://www.marketsandmarkets.com
Content Source: https://www.marketsandmarkets.com/PressReleases/non-invasive-prenatal-testing.asp

Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg